Phibro Animal Health (NASDAQ:PAHC) Price Target Raised to $22.00 at Barclays

Phibro Animal Health (NASDAQ:PAHC - Free Report) had its price objective hoisted by Barclays from $20.00 to $22.00 in a report issued on Monday,Benzinga reports. Barclays currently has an underweight rating on the stock.

A number of other analysts have also recently issued reports on PAHC. StockNews.com cut shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, February 6th. Morgan Stanley lifted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Phibro Animal Health has an average rating of "Hold" and an average target price of $21.00.

Phibro Animal Health Stock Up 2.4 %

Shares of PAHC stock traded up $0.59 during trading on Monday, hitting $25.19. 221,486 shares of the company were exchanged, compared to its average volume of 201,562. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.69 and a current ratio of 3.20. The firm has a market capitalization of $1.02 billion, a price-to-earnings ratio of 52.48, a P/E/G ratio of 0.53 and a beta of 0.52. The business's 50-day simple moving average is $22.03 and its 200 day simple moving average is $21.82. Phibro Animal Health has a twelve month low of $11.24 and a twelve month high of $26.49.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, analysts forecast that Phibro Animal Health will post 1.94 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.91%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health's dividend payout ratio is 100.00%.

Hedge Funds Weigh In On Phibro Animal Health

A number of institutional investors have recently modified their holdings of PAHC. Hussman Strategic Advisors Inc. bought a new position in shares of Phibro Animal Health in the fourth quarter valued at approximately $2,205,000. Jacobs Levy Equity Management Inc. increased its position in Phibro Animal Health by 116.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company's stock worth $4,330,000 after acquiring an additional 103,491 shares during the period. Alliancebernstein L.P. increased its position in Phibro Animal Health by 357.1% during the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock worth $2,730,000 after acquiring an additional 101,560 shares during the period. Prudential Financial Inc. increased its position in Phibro Animal Health by 405.8% during the fourth quarter. Prudential Financial Inc. now owns 120,655 shares of the company's stock worth $2,534,000 after acquiring an additional 96,800 shares during the period. Finally, American Century Companies Inc. increased its position in Phibro Animal Health by 18.0% during the fourth quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after acquiring an additional 96,787 shares during the period. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.